Navigation Links
New target for maintaining healthy blood pressure discovered
Date:4/24/2009

PHILADELPHIA - In trying to understand the role of prostaglandins a family of fatty compounds key to the cardiovascular system in blood pressure maintenance, researchers at the University of Pennsylvania School of Medicine and colleagues discovered that mice that lack the receptor for one type of prostaglandin have lower blood pressure and less atherosclerosis than their non-mutant brethren.

The results indicate that the normal role for the type of prostaglandin studied, PG F2-alphais to increase blood pressure and accelerate atherosclerosis, at least in rodents, and suggest that targeting this pathway could represent a novel therapeutic approach to cardiovascular disease.

The results appeared this week in the Proceedings of the National Academy of Sciences.

"Blocking this prostaglandin receptor may provide a strategy for controlling blood pressure and its attendant vascular disease," notes senior author Garret A. FitzGerald, MD, Director of the Institute for Translational Medicine and Therapeutics at Penn.

To address prostaglandins' role in maintaining blood pressure, FitzGerald and his team, including researchers from the University of Southern Denmark, created strains of mice in which both the maternal and paternal copies of the gene for the PG F2-alphareceptor were deleted. They did this in mice with a normal genetic background and in ones that contained an additional mutation in the low-density lipoprotein receptor gene. These manipulations effectively rendered the mice unable to respond to the prostaglandins.

The delicate balance the body maintains to keep blood pressure stable involves not only the prostaglandin system, but another biological pathway, the renin-angiotensin-aldosterone system, or RAAS. Under conditions of low blood pressure, the liver secretes a protein called angiotensiogen. Renin, an enzyme produced by the kidneys, cleaves angiotensiogen into a p
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Targeted agent shows promise in biliary cancer study
2. USC researchers develop new drug to target tumor cells and blood vessels
3. Targeted Treatments Show Mettle Against Advanced Cancers
4. AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets
5. UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases
6. Test quickly assesses whether Alzheimers drugs are hitting their target
7. A potential new target for treatment of hormone refractory prostate cancer
8. Cellular target may prove useful in treating deadly brain tumors
9. Treatment Target for Herpes Pinpointed
10. Targeting oxidized cysteine through diet could reduce inflammation and lower disease risk
11. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New target for maintaining healthy blood pressure discovered
(Date:2/26/2015)... As the great passage beyond midlife gathers ... more substantial roles and connections that span the generations ... a life that still matters? As The Aspen Club ... Year Total Immersion Retreat , answers to these types ... and jump-starts a healthier life. A new round of ...
(Date:2/26/2015)... Imagine a day without access to clean, drinkable water ... was no one to help. For more than 783 million ... more than 2.5 billion people will also lack access to ... initiative led by Nevada’s Desert Research Institute (DRI) ... women – who often bear the brunt of the impact ...
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 The ... with Topical BioMedics, Inc., Rhinebeck, NY, to offer customers ... creams—patented topical biomedicine formulas that safely and effectively address ... a new division of Vets Access LLC, Montrose, MI, ... and healing products. , Topical BioMedics is a research ...
(Date:2/26/2015)... Scotch Plains, NJ (PRWEB) February 26, 2015 ... celebrating the reopening of their newly renovated office in ... Mann, the Reproductive Science Center of New Jersey’s physicians, ... outstanding work and patient care in the areas of ... is commended for having excellent success rates and providing ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Beckman Coulter ... of extracellular vesicles and their cargo in cell-to-cell communication,” ... and their relevance for cell-to-cell communication. The webinar is ... 4, 2015 at 8:00am PT. , Every cell in ... vesicles (EVs) , often called “exosomes” or “microvesicles.” These ...
Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3
... release are posted on the Mayo,Clinic News Blog: http://newsblog.mayoclinic.org/ ... for TV broadcast upon request., ROCHESTER, Minn. July 31 ... both men and women. For men,the record pace for the ... the 10,000-meter run just after World War II. Today, champion ...
... "open access" or free online, they get read more ... -- get cited more often in academic literature, finds ... student Philip Davis and colleagues, including three Cornell professors, ... access they need to relevant articles. , "It appears ...
... (Nasdaq:,EVVV) today announced that Pat Spangler, chief financial officer, ... at the,Canaccord Adams 28th Annual Global Growth Conference on ... Canaccord Adams 28th Annual Global,Growth Conference will be held ... the webcast, go to the investors, section of the ...
... 31 Halozyme Therapeutics,Inc. (Nasdaq: HALO ), ... extracellular matrix, today,announced that it will release financial ... 30, 2008 before market open on Friday, August ... Chief Executive Officer, Gregory Frost,PhD, Vice President and ...
... of Michigan to spray the state,s apple orchards with ... to treat blood infections in newborns and other serious ... America (IDSA). , The Environmental Protection Agency (EPA) ... to use gentamicin to fight a tree disease called ...
... Stereotaxis, Inc. (Nasdaq:,STXS) announced today that it ... ended June 30, 2008, on Tuesday, August 5, ... a conference call and webcast on,Tuesday, August 5, ... the Company,s,second quarter results and current corporate developments. ...
Cached Medicine News:Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 2Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 3Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 4Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 5Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 6Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 7Health News:Free articles get read but don't generate more citations 2Health News:Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8 2Health News:Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?' 2
(Date:2/26/2015)... , February 27, 2015 ... 2014 market research report to its store. This ... Ulcers, therapeutic pipeline. The report "Corneal ... the therapeutic development for Corneal Ulcers. Corneal Ulcers ... includes bacterial infections, viral infections & fungal infections. ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
(Date:2/26/2015)... 26, 2015 Every year many millions of ... heart disease.  Nevertheless, year after year doctors and the ... the first test to determine the status of heart ... or not, even though that technology is over 100 ... that doctors know, (while most patients do not know) ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2
... Expands Enterprise Intelligence Systems to Healthcare Market, ... Booth #1841 --,Harris Corporation (NYSE: HRS ... has joined forces with Cancer Treatment,Services International ... of,radiation oncology. Harris will provide advanced imaging ...
... InteKrin Therapeutics, Inc.,a privately-held clinical stage biopharmaceutical ... novel drugs for the treatment of,diabetes, obesity ... has,initiated a Phase 2b study in diabetic ... non-TZD SPPARM (Selective Peroxisome,Proliferator-Activated Receptor Modulator). INT131 ...
Cached Medicine Technology:Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2
... is the most potent, naturally secreted estrogen ... the ovary [1]. In the ovary, estradiol ... estrone, a less potent estrogen derived from ... many body tissues. In men, small amounts ...
The second-generation Dade Behring Acute Care Troponin I (cTnI) method is the first FDA cleared high sensitivity cTnI assay with the low-end precision necessary to meet the ESC/ACC guidelines (CV <10...
For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum....
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
Medicine Products: